ir.pieris.com

Overview :: Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin. Technology to create differentiated drugs that may help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma. Pieris Pharma...

http://ir.pieris.com/

OVERVIEW OF ir.pieris.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IR.PIERIS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 14 reviews

5 star

4

4 star

6

3 star

4

2 star

0

1 star

0

Hey there! Start your review of ir.pieris.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.6 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT IR.PIERIS.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

7

SSL

EXTERNAL LINKS

0

SITE IP

54.152.98.57

LOAD TIME

0.641 sec

SCORE

6.2

PAGE TITLE

Overview :: Pieris Pharmaceuticals, Inc. (PIRS) | ir.pieris.com Reviews

<META> DESCRIPTION

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin. Technology to create differentiated drugs that may help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma. Pieris Pharma...

<META> KEYWORDS

1 overview

2 history

3 corporate strategy

4 management team

5 board of directors

6 careers

7 anticalin technology

8 advantages

9 libraries

10 intellectual property

CONTENT

Page content here

KEYWORDS ON PAGE

overview,history,corporate strategy,management team,board of directors,careers,anticalin technology,advantages,libraries,intellectual property,publications,pipeline,proprietary programs,co developed programs,partnered programs,partnering,partners,profile

SERVER

Apache/2.4.12 (Ubuntu)

POWERED BY

PHP/5.5.9-1ubuntu4.11

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Overview :: Pieris Pharmaceuticals, Inc. (PIRS) | ir.pieris.com Reviews

https://ir.pieris.com

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin. Technology to create differentiated drugs that may help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma. Pieris Pharma...

INTERNAL PAGES

ir.pieris.com

1

IR Calendar :: Pieris Pharmaceuticals, Inc. (PIRS)

http://ir.pieris.com/ir-calendar

November 7 - November 9, 2016. November 9 - November 13, 2016. SITC (Society of Immunotherapy of Cancer) Annual Meeting. National Harbor, MD. November 10, 2016 10:00 am ET. Third Quarter 2016 Financial Results Conference Call. To access the call, participants may dial 877-407-8920 (US and Canada) or 412-902-1010 (International) at least 10 minutes prior to the start of the call. November 14 - November 16, 2016. European Antibody Congress 2016. November 16 - November 17, 2016. November 17, 2016. September...

2

Email Alerts :: Pieris Pharmaceuticals, Inc. (PIRS)

http://ir.pieris.com/email-alerts

Please fill out the form below to receive company press releases via email when they occur . Annual & Quarterly Reports. We respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways to which you have consented.

3

Press Releases :: Pieris Pharmaceuticals, Inc. (PIRS)

http://ir.pieris.com/press-releases

Nov 1, 2016. Pieris Pharmaceuticals to Host Third Quarter 2016 Investor Call and Corporate Update on November 10, 2016. Oct 26, 2016. Pieris Pharmaceuticals to Receive GLP Tox Milestone Payment in Daiichi Sankyo Collaboration. Oct 20, 2016. Pieris Announces Presentations at Upcoming R&D Conferences. Sep 26, 2016. Pieris Pharmaceuticals Presents Positive Data for Its Lead Bispecific Drug Candidate, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference. Sep 22, 2016.

4

Press Releases :: Pieris Pharmaceuticals, Inc. (PIRS)

http://ir.pieris.com/press-releases/detail/506/pieris-pharmaceuticals-to-host-second-quarter-2015-investor

Pieris Pharmaceuticals to Host Second Quarter 2015 Investor Call on August 13th. FREISING, GERMANY - (Marketwired) - 07/30/15 -. Pieris Pharmaceuticals, Inc. A biotechnology company advancing its proprietary Anticalin. Biotherapeutic technologies, announced today that it will conduct a conference call on Thursday, August 13 at 10:00 AM (EDT) to discuss second quarter 2015 business and financial results. Pieris is a clinical-stage biotechnology company advancing its proprietary Anticalin. Source: Pieris P...

5

10-Q

http://ir.pieris.com/all-sec-filings/content/0001193125-15-290039/d947317d10q.htm

SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, DC 20549. QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2015. TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from. Commission file number: 001-37471. PIERIS PHARMACEUTICALS, INC. Exact name of registrant as specified in its charter). State or other jurisdiction of. Address of principal executive offices).

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

OTHER SITES

ir.pharmacytebiotech.com

PharmaCyte Biotech, Inc. (PMCB)

Research & Development. Medical and Scientific Advisory Board. Shareholder Calls / Presentations. 8211; Live Cell Encapsulation. 8211; Research & Development. 8211; Board of Directors. 8211; Medical and Scientific Advisory Board. 8211; International Diabetes Consortium. 8211; News / Events. 8211; Company Information. 8211; Financial Information. 8211; Stock Data. 8211; SEC Filings. 8211; Corporate Governance. 8211; Photo Gallery. Shareholder Calls / Presentations. 10 Jan, 2017. Sign up for email alerts.

ir.pharmathene.com

PharmAthene | Investor Relations | Overview

Dedicated to a Safer World. PharmAthene vs. SIGA Technologies. PharmAthene was formed in 2001 to meet the critical needs of this Nation and its Allies by developing biological and chemical defense products. The Company is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used. More. NYSE Amex -. 160;- 0.01. 08/07/15 4:00 pm ET. Data Provided by Thomson Reuters. There are currently no events scheduled. Replication or redistr...

ir.phh.com

PHH Corporation - Investors Overview

Annual Report and Proxy. RSS and E-mail Alerts. Annual Report and Proxy. RSS and E-mail Alerts. Q2 2015 PHH CORP Earnings Conference Call. 160;at 10:00 am ET. Q2 2015 PHH CORP Earnings Conference Call. Thursday, August 6, 2015 . 10:00 am ET . Click here for webcast. Click here to add this event to your calendar. PHH Corporation Announces Second Quarter 2015 Results. PHH Corporation Announces Second Quarter 2015 Earnings Release and Conference Call Schedule. Open High Low Close (OHLC).

ir.phonegg.com

جدیدترین گوشی ها

Samsung Galaxy S6 edge. Samsung Galaxy Note 5. ZTE Nubia My Prague. Verykool s3504 Mystic II. Micromax Canvas Xpress 2 E313. Asus Zenfone Max ZC550KL. Asus Zenfone 2 Deluxe ZE551ML. Asus Zenfone 2 Laser ZE550KL. Meizu m2 note 32GB. Samsung Galaxy Grand Prime G530Y. Motorola Moto G 4G Dual SIM 2nd Gen. Microsoft Lumia 640 XL. مقایسه های پر طرفدار. Samsung Galaxy S6 edge vs. Huawei Mate 8. Samsung Galaxy S6 edge vs. Samsung Galaxy S6. Motorola Moto E Dual SIM 2nd Gen vs. HTC Desire 526. برند های پر طرفدار.

ir.php.net

PHP: Hypertext Preprocessor

Predefined Interfaces and Classes. Context options and parameters. Supported Protocols and Wrappers. Installed as CGI binary. Installed as an Apache module. HTTP authentication with PHP. Command Line Specific Extensions. Compression and Archive Extensions. Date and Time Related Extensions. File System Related Extensions. Human Language and Character Encoding Support. Image Processing and Generation. Variable and Type Related Extensions. PHP 56.35 Released. The list of changes is recorded in the ChangeLog.

ir.pieris.com

Overview :: Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin. Technology to create differentiated drugs that may help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma. Pieris Pharma...

ir.pine.com

Banco Pine

Board of Directors and Executives. Financial Statements - Res. 4280. Presentations and Conference Calls. Global Reporting Initiative (GRI). Which language do you prefer? My Downloads ( 0 ). Board of Directors and Executives. Financial Statements - Res. 4280. Presentations and Conference Calls. Global Reporting Initiative (GRI). To access 2Q15 results. The new Investor Relations'. Website is now online. 08/14/2015 - 2Q15 Institutional Presentation. 08/13/2015 - 2Q15 Earnings Conference Call. Register your...

ir.pingan.com

投资者关系首页-中国平安

ir.pitt.edu

Institutional Research - University of Pittsburgh |

Tuition & Fees. Undergraduate Tuition & Fees. Graduate Tuition & Fees. Historical Tuition & Fees. Facts & Publications. Management Information Center Required Login. Tuition & Fees. Undergraduate Tuition & Fees. Graduate Tuition & Fees. Historical Tuition & Fees. Facts & Publications. Management Information Center Required Login. IR is an office that is officially designated for the reporting of University data. IR provides data and information to the University community as well as external agencies...

ir.pku.edu.cn

Institutional Repository of Peking University: Home

The brand new way to explore Peking University Institutional Repository. Peking University Institutional Repository (PKU IR) is the academic research infrastructure of Peking University. It's a central, open-access repository of research by members of the Peking University. Beijing da xue xue bao yi xue ban. Institutional Repository Project Group, Powered by DSpace Feedback.

ir.platformspecialtyproducts.com

Investor Relations - Platform Specialty Products Corporation

London Stock Exchange Historic Stock Lookup. Platform Specialty Products Corporation Announces Proposed Acquisition of Alent plc. Aug 13, 2015. Platform Specialty Products Corporation Announces Second Quarter 2015 Financial Results. Jul 16, 2015. Platform Specialty Products Corporation Announces Date for Release of Second Quarter 2015 Financial Results. View all press releases ». Aug 13, 2015 at 8:00 AM ET. Platform Specialty Products Corporation's Second Quarter Financial Results Call.